| 000 | 01530 a2200433 4500 | ||
|---|---|---|---|
| 005 | 20250513153457.0 | ||
| 264 | 0 | _c19981030 | |
| 008 | 199810s 0 0 eng d | ||
| 022 | _a0028-3878 | ||
| 024 | 7 |
_a10.1212/wnl.51.4.1093 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aStahl, J S | |
| 245 | 0 | 0 |
_aClinical evidence of extraocular muscle fiber-type specificity of botulinum toxin. _h[electronic resource] |
| 260 |
_bNeurology _cOct 1998 |
||
| 300 |
_a1093-9 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.; Research Support, U.S. Gov't, P.H.S. | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 |
_aAnti-Dyskinesia Agents _xadverse effects |
| 650 | 0 | 4 |
_aBotulinum Toxins _xadverse effects |
| 650 | 0 | 4 |
_aBotulism _xphysiopathology |
| 650 | 0 | 4 |
_aDiplopia _xchemically induced |
| 650 | 0 | 4 | _aEdrophonium |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aMuscle Fibers, Skeletal _xmicrobiology |
| 650 | 0 | 4 |
_aOculomotor Muscles _xcytology |
| 650 | 0 | 4 |
_aOphthalmoplegia _xchemically induced |
| 650 | 0 | 4 | _aParasympathomimetics |
| 650 | 0 | 4 |
_aPursuit, Smooth _xdrug effects |
| 650 | 0 | 4 |
_aSaccades _xdrug effects |
| 700 | 1 | _aAverbuch-Heller, L | |
| 700 | 1 | _aRemler, B F | |
| 700 | 1 | _aLeigh, R J | |
| 773 | 0 |
_tNeurology _gvol. 51 _gno. 4 _gp. 1093-9 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1212/wnl.51.4.1093 _zAvailable from publisher's website |
| 999 |
_c9746129 _d9746129 |
||